Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Gastric Cancer (GC): later-stage trial registry

2 of 2 indexed Gastric Cancer (GC) trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Gastric Cancer (GC): 2 US clinical trials tracked, 2 recruiting.

Gastric Cancer (GC) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is SOFIE, running 1 of these trials.

Enrollment posture brief

Registry condition gastric-cancer-gc

OPEN 2 | RECR 100% | LATE 1 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Gastric Cancer (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Gastric Cancer (GC)

Gastric Cancer (GC) lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Gastric Cancer (GC) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Gastric Cancer (GC) is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

Named interventions

Most-linked intervention names on Gastric Cancer (GC) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

[18f]fapi-74 Pet/ct Drug
1 trials

US sites by state

Facility locations filed on Gastric Cancer (GC) trials. A trial with sites in several states counts in each.

California 2 trials
Ohio 1 trials
New York 1 trials
Massachusetts 1 trials
Indiana 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Gastric Cancer (GC) page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Gastric Cancer (GC) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • SOFIE sponsors the most Gastric Cancer (GC) trials on record, review their full trial history before evaluating a specific study. See SOFIE's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Gastric Cancer (GC) condition card totals 2 registered trials; most-linked intervention [18f]fapi-74 Pet/ct; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.